Cumberland Pharmaceuticals (CPIX) Proxy Filing summary

Executive summary

• Annual Meeting of Shareholders scheduled for April 21, 2026, at the company's Nashville headquarters.

• Shareholders of record as of February 27, 2026, are eligible to vote on key proposals.

• Proxy materials, including the Notice, Proxy Statement, and Annual Report, are available online.

Voting matters and shareholder proposals

• Election of two directors: Kenneth Krogulski and Caroline Young.

• Ratification of Carr, Riggs & Ingram, L.L.C. as independent registered accounting firm for fiscal year ending December 31, 2026.

• Advisory approval of executive compensation, including Compensation Discussion and Analysis.

• Advisory vote on the frequency of executive compensation votes, with the Board recommending every three years.

• Proxies may vote on other business as may properly come before the meeting.

Board of directors and corporate governance

• Board recommends voting FOR all director nominees and proposals, and every three years for the say-on-pay frequency.

• Proxies appointed with full power of substitution to represent shareholders at the meeting.